Subject
Obstetrics and Gynaecology,Oncology
Reference4 articles.
1. Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: Lessons learned from a gynecologic oncology group Phase II trial of ip cisplatin and recombinant α-interferon;Markman;Gynecol. Oncol.,1992
2. Responses to secondline cisplatin-based intraperitoneal therapy in ovarian cancer: Influence of a prior response to intravenous cisplatin;Markman;J. Clin. Oncol.,1991
3. Alberts, D. Principle investigator INT-0051: Phase III intraperitoneal cisplatin/intravenous cyclophosphamide versus intravenous cisplatin/intravenous cyclophosphamide in patients with nonmeasurable stage III ovarian cancer, unpublished.
4. EORTC Trial. Randomized trial of ip cisplatin in ovarian cancer patients with a complete remission. In progress.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献